LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Overview Fund Activity
Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

36 hedge funds and large institutions have $131M invested in LogicBio Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
36
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$67.3M
2
RG
2
Redmile Group
California
$9.48M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$9.46M
4
BOTOTLSJU
4
Board of Trustees of The Leland Stanford Junior University
California
$9.46M
5
Franklin Resources
5
Franklin Resources
California
$7.28M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
AIG
26
American International Group
New York
$56K +$56K +5,350 New
Bank of America
27
Bank of America
North Carolina
$34K +$34K +3,356 New
Victory Capital Management
28
Victory Capital Management
Texas
$31K +$31K +3,000 New
UBS Group
29
UBS Group
Switzerland
$31K +$31K +3,003 New
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$26K +$26K +2,445 New
SO
31
STRS Ohio
Ohio
$22K +$22K +2,200 New
Barclays
32
Barclays
United Kingdom
$21K +$21K +1,998 New
Legal & General Group
33
Legal & General Group
United Kingdom
$13K +$13K +1,259 New
AIP
34
Ameritas Investment Partners
Nebraska
$7K +$7K +670 New
CCA
35
Catalyst Capital Advisors
New York
$6K +$6K +620 New
Citigroup
36
Citigroup
New York
$5K +$5K +489 New
1
2